Implications for Future Pandemic Readiness and Platform Vaccine Funding The Department of Health and Human Services’ decision to terminate multiple pandemic-era mRNA vaccine development programs
How the GAO’s Illegal Withholding Decision Changes NIH Leverage Over Grantees The Government Accountability Office’s (GAO) bombshell ruling that the National Institutes of Health violated
How Upcoming Tariffs Could Reshape Drug Pricing, Global Manufacturing, and Supply Chains President Trump’s latest threat to impose tariffs reaching 250% on pharmaceutical imports represents
Quick Summary •Market Reaction: Biotech stocks saw modest gains following Trump’s 2024 election victory, reflecting optimism about regulatory leniency and M&A activity. •Key Appointments: Speculation
